Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -324 | 1,456 | 2,971 | -49,048 | -4,762 |
| Depreciation Amortization | 183 | 45 | 66 | 50 | 40 |
| Income taxes - deferred | N/A | N/A | N/A | -13,582 | -1,459 |
| Accounts receivable | -768 | -914 | -1,078 | N/A | N/A |
| Other Working Capital | -178 | -547 | -925 | 117 | -71 |
| Other Operating Activity | 754 | 950 | 984 | 54,173 | -68 |
| Operating Cash Flow | $-333 | $990 | $2,018 | $-8,290 | $-6,320 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -144 | -29 | -25 | -28 | -13 |
| Other Investing Activity | 0 | 0 | 0 | 1,400 | 1,400 |
| Investing Cash Flow | $-144 | $-29 | $-25 | $1,372 | $1,387 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,000 | 1,000 |
| Common Stock Issued | 3,928 | 3,928 | 3,928 | 7,912 | 7,869 |
| Other Financing Activity | -159 | -117 | -52 | -19 | 0 |
| Financing Cash Flow | $3,769 | $3,811 | $3,876 | $8,893 | $8,869 |
| Beginning Cash Position | 2,752 | 2,752 | 2,752 | 777 | 777 |
| End Cash Position | 6,044 | 7,524 | 8,621 | 2,752 | 4,713 |
| Net Cash Flow | $3,292 | $4,772 | $5,869 | $1,975 | $3,936 |
| Free Cash Flow | |||||
| Operating Cash Flow | -333 | 990 | 2,018 | -8,290 | -6,320 |
| Capital Expenditure | -144 | -29 | -25 | -28 | -13 |
| Free Cash Flow | -477 | 961 | 1,993 | -8,318 | -6,333 |